ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.
Kataja
V V
VV
Invited author and member of the task force, University Hospital of Kuopio, POB 1777, FIN-70 211 Kuopio, Finland.
Bergh
J
J
D000726:Androgen Antagonists / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D018570:Risk Assessment
D000726:Androgen Antagonists